FindTrial
Sign In

80MG ATORVASTATIN THERAPY IN PATIENTS WITH ST ELEVATION MYOCARDIAL INFARCTION TREATED WITH PRIMARY PTCA - CARDIOTA80-2009

80MG ATORVASTATIN THERAPY IN PATIENTS WITH ST ELEVATION MYOCARDIAL INFARCTION TREATED WITH PRIMARY PTCA - CARDIOTA80-2009

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2009-012120-89-IT
Enrollment
Unknown
Registered
2009-05-20
Start date
2009-09-23
Completion date
Unknown
Last updated
2012-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ST elevation Myocardial Infarct MedDRA version: 9.1 Level: LLT Classification code 10064346 Term: STEMI

Interventions

Pharmaceutical Form: Coated tablet INN or Proposed INN: Atorvastatin Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 80- Pharmaceutical Form: Coated tablet INN or

Sponsors

AZIENDA OSPEDALIERA SPEDALI CIVILI DI BRESCIA
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Age 20 - 75 years ST elevation myocardial infarction Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: Non ST elevation infarct Unstable Angina Heart Shock Intollerance statine therapy

Design outcomes

Primary

MeasureTime frame
Main Objective: EVALUATION OF EARLY INTENSIVE STATINE TREATMENT ON PATIENTS UNDERGOING PRIMARY PTCA WITH ST ELEVATION MYOCARDIAL INFARCTION;Secondary Objective: INFLAMMATORY MARKERS EVALUATION;Primary end point(s): Recurrence of cardiovascular events (Myocardial infarction fatal - non fatal, stroke, reospedalization for unstable angina, arterial revascularization)—

Countries

Italy

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026